The newly released ACC/AHA/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome represents an important step toward a more integrated approach to patient care.
The guideline recognizes the strong interconnection between cardiovascular disease, chronic kidney disease, diabetes, obesity, and other metabolic disorders, emphasizing that these conditions should no longer be managed in isolation. Instead, it promotes a coordinated, multidisciplinary strategy focused on early detection, risk assessment, prevention, and treatment across the CKM continuum.
Key highlights include:
• Earlier identification of CKM risk factors and disease stages
• Greater emphasis on obesity and metabolic health as drivers of cardiovascular and kidney disease
• Integration of cardiovascular, renal, and metabolic risk assessment into routine clinical care
• Evidence-based recommendations for lifestyle interventions and emerging therapies
• A patient-centered approach that encourages collaboration across specialties
As the burden of cardiometabolic disease continues to grow, this guideline provides a valuable framework for clinicians, researchers, and health systems working to improve outcomes through prevention and comprehensive care.
For centers like CICMD, the guideline reinforces the importance of bringing together basic, clinical, and population scientists to address these interconnected diseases through collaborative research and innovation.
#CardiovascularHealth #KidneyHealth #MetabolicHealth #CKMSyndrome #ACC #AHA #CardiometabolicDisease #Diabetes #Obesity #Prevention #TranslationalResearch #CICMD
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.https://www.ahajournals.org/doi/10.1161/CIR.0000000000001453